Status:
UNKNOWN
50% Nitrous Oxide and 50% Oxygen (MEOPA) Conscious Sedation Versus Placebo in Fiberoptic Bronchoscopy
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Fiberoptic Bronchoscopy
Eligibility:
All Genders
18-90 years
Phase:
PHASE3
Brief Summary
Fiberoptic bronchoscopy may generate pain, anxiety or cough and dyspnea. It may then induce discomfort and then run down its yield. Systematic local anaesthesia does not always suffice and FOB may be ...
Eligibility Criteria
Inclusion
- Man or woman over 18 who should undergo a fiberoptic bronchoscopy (inpatient and outpatient)
Exclusion
- Child under 18
- Pneumothorax
- ocular surgery in the previous 3 months,
- intracranial overpressure
- lucidity impairment
- emphysema bullae
- face trauma
- angina pectoris
- hemodynamic instability
- acute respiratory distress
- hypercapnia \> 45 mm Hg
- pregnancy
- lidocaine allergia
- lack of approuval from the patient to perform the study will of the patient to undergo FOB with premixed nitrous oxide-oxygen
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00392522
Start Date
November 1 2006
Last Update
October 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Corinne Depagne
Lyon, France, 69004